A Comparison of Merkel Cell Carcinoma and Melanoma: Results from the California Cancer Registry
Julia Grabowski1, Sidney L Saltzstein1,2,3,4, Georgia Robins Sadler3,4, Zunera Tahir4 and Sarah Blair3,4
1Department of Family and Preventive Medicine, University of California at San Diego School of Medicine, La Jolla, CA. 2Department of Pathology, University of California at San Diego School of Medicine, La Jolla, CA. 3Department of Surgery, University of California at San Diego School of Medicine, La Jolla, CA. 4Rebecca and John Moores UCSD Cancer Center, University of California at San Diego School of Medicine, La Jolla, CA.
Abstract
Introduction: Melanoma and Merkel cell carcinoma (MCC) are both aggressive skin malignancies associated with immunosuppression and possible UV exposure. Both tumors get similar surgical treatment; however, MCC is a relatively rare tumor in which less is known about prognosis and clinical behavior.
Methods: The California Cancer Registry (CCR), a population-based registry, was reviewed from the years 1988–2003. Merkel cell carcinoma and melanoma were compared with relation to gender, age, ethnicity, disease stage, site, and survival.
Results: A total of 113,187 cases of melanoma and 1,878 cases of MCC were identified in the CCR. Though both cancers are more common in men than in women, MCC had a higher incidence in men than melanoma (63% vs 57% p < 0.005). MCC occurs in the more elderly, with 73.6% of cases occurring in people over 70 years. In contrast, 69% of melanoma cases occurred in people younger than 70 years (p < 0.005). MCC shows a predilection for the head and neck compared to melanoma (47% vs 25.8%) Additionally, melanoma occurs more frequently on the trunk than MCC (30% vs 8.7%). Finally, the 10-year cumulative survival is lower for MCC than for melanoma (17.7% vs 61.3%, p < 0.005).
Conclusion: Many clinicians assume MCC and melanoma behave similarly. However, MCC occurs in an older population, more frequently on the head and neck, in a higher percentage of men. Additionally, MCC has a higher rate of regional metastasis and thus may have more of a benefit from regional staging procedures. Overall, MCC has a worse prognosis.
Readers of this also read:
- Mitochondrial Defects in Breast Cancer
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- Signal Transduction Involving the Dmp1 Transcription Factor and its Alteration in Human Cancer
- A Hybrid Lesion of Lung Cancer and Aspergillosis
- Cancer Informatics in the U.K.: The NCRI Informatics Initiative